Thorigne-Fouillard, France

Yannick Arlot

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Université De Rennes 1. Active years: 2012.


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yannick Arlot: Innovator in Antimitotic Compounds

Introduction

Yannick Arlot is a notable inventor based in Thorigne-Fouillard, France. He has made significant contributions to the field of chemistry, particularly in the development of antimitotic compounds. His work has implications for cancer treatment and other medical applications.

Latest Patents

Yannick Arlot holds a patent for "Anti-tubulin acting arylpyrrol, arylfuran and arylthiophene derivatives, method for the preparation thereof and for the use thereof as an antimitotic." This invention relates to a compound represented by a general formula where Z can be N, O, or S, and A can represent a CH group, a nitrogen atom, or an NL group, with L being a straight-chained or branched C-C alkyl group. The patent outlines both the preparation method and the use of these compounds as antimitotic agents.

Career Highlights

Throughout his career, Yannick has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and the Université de Rennes 1. His research has focused on innovative solutions in the field of medicinal chemistry.

Collaborations

Yannick has collaborated with notable colleagues, including Olivier Paulus and Gilles Alcaraz. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Yannick Arlot is a distinguished inventor whose work in antimitotic compounds showcases his commitment to advancing medical science. His contributions are valuable in the ongoing fight against cancer and highlight the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…